TELA Bio (TELA) Treasury Shares (2018 - 2019)
TELA Bio (TELA) posted Treasury Shares of $75.6 million for Q3 2019, up 2.68% on a QoQ basis from $73.6 million in Q2 2019, and up 24.44% year-over-year from $60.7 million in Q3 2018.
Powered by 
Analysis
TELA Bio (TELA) Treasury Shares (2018 - 2019) Analysis & Trends
TELA Bio has reported Treasury Shares for 2 years, with the latest figure at $75.6 million in Q3 2019.
- On a quarterly basis, Treasury Shares rose 24.44% year-over-year to $75.6 million in Q3 2019; TTM through Sep 2019 was $75.6 million, a 24.44% increase from a year earlier, with the FY2017 full-year figure at $59.4 million, changed N/A from the prior year.
- Treasury Shares was $75.6 million for Q3 2019 at TELA Bio, up from $73.6 million in the prior quarter.
- The five-year high for Treasury Shares was $75.6 million in Q3 2019, with the low at $60.7 million in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 267.91 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 303.21 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 7.67 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 35.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | TELA Bio | 50.22 Mn | 19.80 Mn | 13.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 75.56 Mn |
| Sep 30, 2019 | 75.56 Mn |
| Jun 30, 2019 | 73.59 Mn |
| Jun 30, 2019 | 73.59 Mn |
| Mar 31, 2019 | 63.46 Mn |
| Mar 31, 2019 | 63.46 Mn |
| Sep 30, 2018 | 60.72 Mn |
| Sep 30, 2018 | 60.72 Mn |